Start Date
January 31, 2016
Primary Completion Date
April 30, 2017
Study Completion Date
April 30, 2018
TDENV-PIV
Single-dose vial with pre-filled syringe, subcutaneous injection
TDENV-F17
Single-dose vial with pre-filled syringe 0.5 mL administered intramuscularly
Placebo
0.5 mL vial
Upstate Medical University, SUNY, Syracuse
Collaborators (1)
Walter Reed Army Institute of Research (WRAIR)
FED
GlaxoSmithKline
INDUSTRY
U.S. Army Medical Research and Development Command
FED